share_log

SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.

Aug 22, 2022 16:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more